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Abstracts / Urological Science 27 (2016) S53eS83S56involvement of the ER This mechanism of action or a different ER perfor-
mance. Clarify the ER estrogen stimulation of prostate cancer will be as
before this laboratory study in renal cancer cells by inhibiting AKT
pathway to inhibit tumor role.
Results: We found prostate cancer growth was inhibited by certain level of
Estrogen. The survival of prostate cancer was reduced up to 30%. Besides,
migration and invasion of prostate cancer cell were also inhibited by Es-
trogen. Estrogen also stimulate VEGFR signal of prostate cancer cell.
Conclusion: Estrogen has direct inhibitory effect on prostate cancer cell
growth. Further studies to identify the mechanism of Estrogen, androgen
receptor, RAS, EGFR pathway are needed.
NDP012:
EVALUATION OF FLUORODEOXYGLUCOSE POSITRON EMISSION
TOMOGRAPHY/COMPUTED TOMOGRAPHY FOR DIAGNOSIS AND
STAGING OF UPPER URINARY TRACT UROTHELIAL CARCINOMA
Kuan-Hsun Huang, Chien-Hui Ou, Wen-Horng Yang. Department of
Urology, Medical College and Hospital, National Cheng-Kung University,
Tainan, Taiwan
Purpose: To evaluate the ability of Fluorodeoxyglucose positron emission
tomography /computed tomography (18F-FDG PET-CT) in primary diag-
nosis and detection of upper urinary tract urothelial carcinoma by
comparing with ﬁnal pathological result.
Materials and Methods: We retrospectively evaluated clinicopathological
records of patients in our institute. All patients suspicious to have upper
urinary tracts malignancies were received 18F-FDG PET-CT, which was
followed by pathological-proved procedures such as ureteroscopic biopsy,
CT-guide biopsy, Nephroureterectomy or Hand-assisted Retroperitoneo-
scopic Nephroureterectomy (HARN). 21 patients were included in this
study. There were 12 women and 9 men with a median age of 76 years old
(range 34~89y/o).
Results: Of 21 patients in study group, 12 patients received HARN, 3 had
URS biopsy, 1 CT-guide biopsy and 5 open Nephroureterectomy. There
were 5, 3, 5, 7 patients with pTa, pT1, pT2, pT3 respectively. 3 patients were
diagnosed with lymph nodes metastasis by PET-CT, and 2 patients with
tissue proved lymph node metastasis. 20 showed deﬁnite FDG uptake in
initial or delay phase. Positive predictive rate was 95 %.
Conclusion: These preliminary results of this study with small number of
patients showed that FDG-PET/CT is another effective diagnosis in detec-
tion of UTUC.
NDP013:
THE PROGNOSTIC IMPACT OF MULTIFOCALITY FOR UPPER TRACT
UROTHELIAL CARCINOMA PATIENTS AFTER RADICAL
NEPHROURETERECTOMY
Ta-Yao Tai, Chien-Hui Ou. Department of Urology, National Cheng Kung
University Hospital, Tainan, Taiwan
Purpose: To evaluate the association between tumor multifocality of up-
per urinary tract urothelial carcinoma (UTUC) patients underwent radical
nephroureterectomy and validate the impact on oncologic outcomes in
those patients.
Materials and Methods: Patients who underwent nephroureterectomy
between November 2003 and November 2013 were identiﬁed from Na-
tional Cheng Kung University Hospital (NCKUH). Outcomes were ob-
tained via retrospective analysis of notes and electronic records. Overall
survival (OS), bladder recurrence-free survival (BRFS) were estimated
using KaplaneMeier methods and grade-stratiﬁed differences were
analyzed using the log-rank test. Tumor multifocality of UTUC was
deﬁned as the synchronous presence of multiple tumors in the renal
pelvis or ureter.
Results: Between November 2003 and November 2013, 269 patients un-
derwent nephroureterectomy of UTUC with a median age at diagnosis of
68 years. Median (range; mean) follow-up was 29 (2e120; 35.3) months.
In total, 34.5% (n¼ 69) of the patients had multifocal disease. The esti-
mated OS in multifocal tumor group and single tumor group were 58.8%
and 77.6%, respectively, at 5 years, and 44.1% and 59.7%, respectively, at 10
years (p¼ 0.0225). The estimated mean BRFS in multifocal tumor patientsand single tumor patients was 50.7% and 79.5%, respectively at 2 years and
47.8% and 74.5%, respectively, at 5 years (p<0.0001).
Conclusion: In this present single center cohort study, tumor multifocality
is an independent prognostic indicator of overall survival and bladder
recurrence-free survival in patients with UTUC treated with nephrour-
eterectomy.
NDP014:
CLINICAL FEATURES OF PATIENTS WITH NON-MALIGNANT UPPER
TRACT LESIONS MIMICKING UROTHELIAL CANCER
Ze-Hong Lu, Chien-Hui Ou. Department of Urology, National Cheng Kung
University Hospital, College of Medicine, National Cheng Kung University,
Tainan, Taiwan
Purpose: The aim of this retrospective study was to evaluate the incidence
and clinical features of patients undergone nephroureterectomy with non-
malignant upper tract lesions presumed to be urothelial carcinoma. The
clinicopathologic characteristics of these lesions were also determined.
Material and methods: Between Oct 2004 and Oct 2015, 350 patients
underwent retroperitoneoscopic nephroureterectomy for possible upper
urinary tract urothelial carcinoma without routinely ureteroscopic biopsy
of lesions at our institute. Twenty-three (6.6%) had non-malignant benign
lesions at the ﬁnal pathologic examination. The preoperative features of
these patients were investigated, including imaging ﬁndings, urine cyto-
logic results, and renal function status and previous history.
Results: The 23 patients comprised 9 men and 14 women. Initial symp-
toms included gross hematuria, hydronephrosis or repeated pyelone-
phritis. Urine cytologywere also collected for evaluation.We also reviewed
available abdomen computed tomography and retrograde pyelogram.
Three patients underwent preoperative ureteroscopy. 11 patients
(including 2 patient was post kidney transplantation status) had non-
functional kidney. We divided patient into two groups by renal function
status. The most common pathologic feature of ESRD group is atrophic
kidney. In the other hand, the most common diagnosis of the other group
of non-ERSD is pyelonephritis.
Conclusion: Non-malignant pathologic lesions were detected in twenty-
three (6.6%) patients who had undergone retroperitoneoscopic neph-
roureterectomy without preoperative ureteroscopic biopsies of uppertract
lesions.
NDP015:
CLINICAL AND THERAPEUTIC IMPLICATIONS OF NEUROENDOCRINE
PROSTATE CANCER: A LONG WINDING ROAD TO CURE
Chia-Lung Tsai, Kevin Lu, Hua-Pin Wang, Victor Chia-Hsiang Lin,
Tsan-Jung Yu. Division of Urology, Department of Surgery, E-Da Hospital,
School of Medicine, I-Shou University, Kaohsiung city, Taiwan
Purpose: Primary neuroendocrine cancer of prostate is an extremely rare
variant of prostate cancer, comprising 0.5% to 2% of prostate malignancies.
This entity encompasses various clinical contexts, ranging from the de
novo small cell carcinoma (SCC) to a treatment-emergent transformed
phenotype that arising from typical adenocarcinoma (Ad) of the prostate.
The rarity of these neoplasms poses a diagnostic and therapeutic chal-
lenge. Little is known about neuroendocrine prostate cancer and the cur-
rent knowledge of this disease is based on case reports or small series. Our
purpose was to characterize the cases treated at a tertiary academic center
and to evaluate patient outcomes with the available treatment modalities.
Materials and Methods: This was a single-institute retrospective obser-
vational cohort study of patients with neuroendocrine prostate cancer
followed at E-Da Hospital, Kaohsiung city, Taiwan between January 1, 2008
and October 1, 2013. Patient and tumor data were analyzed using
descriptive statistical methods.
Results: Among 826 prostate cancers, six patients were identiﬁed with
primary neuroendocrine prostate cancer, comprising 3 from de novo
mixed variety (SCC and Ad) and 3 from transformed phenotype (pure SCC).
The median age at diagnosis was 73.5 years. The most common presenting
symptoms were obstructive symptoms (weak stream, incomplete empty
and urine retention). The morphological appearance of the tumor cells and
their immunohistochemical reactivity for neuroendocrine markers, and
